|
Volumn 38, Issue 5, 2011, Pages 612-
|
Introduction: Advances in myelodysplastic syndromes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
ANTIBIOTIC AGENT;
AZACITIDINE;
DNA METHYLTRANSFERASE INHIBITOR;
GROWTH FACTOR;
LENALIDOMIDE;
SEX HORMONE;
THALIDOMIDE;
ACUTE GRANULOCYTIC LEUKEMIA;
ALLOGENEIC STEM CELL TRANSPLANTATION;
BONE MARROW BIOPSY;
CHROMOSOME DELETION 5;
COMORBIDITY;
DRUG TREATMENT FAILURE;
EDITORIAL;
EPIGENETICS;
GENE MUTATION;
GENE SEQUENCE;
HUMAN;
INTERNATIONAL PROGNOSTIC SCORING SYSTEM;
MALIGNANT TRANSFORMATION;
MYELODYSPLASTIC SYNDROME;
NONHUMAN;
PRIORITY JOURNAL;
PROGNOSIS;
TRANSFUSION;
TREATMENT RESPONSE;
HUMANS;
MYELODYSPLASTIC SYNDROMES;
|
EID: 80053217330
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: 10.1053/j.seminoncol.2011.06.001 Document Type: Editorial |
Times cited : (1)
|
References (0)
|